BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20472164)

  • 21. Adjuvant early and late cardioprotective therapy: access to the heart.
    Hinkel R; Boekstegers P; Kupatt C
    Cardiovasc Res; 2012 May; 94(2):226-36. PubMed ID: 22318936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

  • 23. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.
    Gerczuk PZ; Kloner RA
    J Am Coll Cardiol; 2012 Mar; 59(11):969-78. PubMed ID: 22402067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
    Kharbanda RK
    Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
    [No Abstract]   [Full Text] [Related]  

  • 26. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs.
    Andreka G; Vertesaljai M; Szantho G; Font G; Piroth Z; Fontos G; Juhasz ED; Szekely L; Szelid Z; Turner MS; Ashrafian H; Frenneaux MP; Andreka P
    Heart; 2007 Jun; 93(6):749-52. PubMed ID: 17449499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-conditioning for cardioprotection during reperfusion therapy: too good to be true?
    Prasad A
    JACC Cardiovasc Interv; 2010 Jan; 3(1):56-7. PubMed ID: 20129569
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.
    Hausenloy DJ; Yellon DM
    Heart; 2007 Jun; 93(6):649-51. PubMed ID: 17502643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial.
    Tarantini G; Favaretto E; Napodano M; Perazzolo Marra M; Cacciavillani L; Babuin L; Giovagnoni A; Renda P; De Biasio V; Plebani M; Mion M; Zaninotto M; Mistrorigo F; Panfili M; Isabella G; Bilato C; Iliceto S
    Cardiology; 2010; 116(2):110-6. PubMed ID: 20588019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine reduces the threshold of remote ischemic preconditioning against myocardial ischemia and reperfusion injury in rats: the role of opioid receptors.
    Lu Y; Dong CS; Yu JM; Li H
    J Cardiothorac Vasc Anesth; 2012 Jun; 26(3):403-6. PubMed ID: 21982329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ischemic postconditioning: an effective strategy of myocardial protection?].
    Rastaldo R; Penna C; Cappello S; Mancardi D; Pagliaro P; Losano G
    G Ital Cardiol (Rome); 2006 Jul; 7(7):464-73. PubMed ID: 16977786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction].
    Ma XJ; Zhang XH; Luo M; Li CM; Shao JH
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):114-7. PubMed ID: 17418019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundamentals of reperfusion injury for the clinical cardiologist.
    Verma S; Fedak PW; Weisel RD; Butany J; Rao V; Maitland A; Li RK; Dhillon B; Yau TM
    Circulation; 2002 May; 105(20):2332-6. PubMed ID: 12021216
    [No Abstract]   [Full Text] [Related]  

  • 36. Interventions for improving blood flow, oxygen availability and the balance between oxygen supply and demand in the acutely ischaemic myocardium.
    Parratt JR; Marshall RJ; Ledingham IM
    J Physiol (Paris); 1980; 76(7):791-803. PubMed ID: 6111608
    [No Abstract]   [Full Text] [Related]  

  • 37. Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.
    Tosaka S; Tosaka R; Matsumoto S; Maekawa T; Cho S; Sumikawa K
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):72-8. PubMed ID: 20938040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A future for remote ischaemic conditioning in high-risk patients.
    Hausenloy DJ; Ntsekhe M; Yellon DM
    Basic Res Cardiol; 2020 Apr; 115(3):35. PubMed ID: 32335728
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac pre- and post-conditioning: implications in anesthesia?
    Pesonen E
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size.
    Roesner JP; Mersmann J; Bergt S; Bohnenberg K; Barthuber C; Szabo C; Nöldge-Schomburg GE; Zacharowski K
    Shock; 2010 May; 33(5):507-12. PubMed ID: 20395771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.